Back to today’s briefing

Story perspectives

Optum Rx Cuts Medication Reauthorizations by 25% for Patients

3/19/2025

38 7

Summary

Story summary

Optum Rx, part of UnitedHealth Group, is set to cut up to 25% of medication reauthorizations, streamlining access for patients with chronic conditions like cystic fibrosis. This significant shift will impact over 10% of prior authorizations, though safety concerns will still necessitate reauthorizations for certain medications, including new Alzheimer's treatments.

1 of 1

Story summary

Optum Rx, part of UnitedHealth Group, is set to cut up to 25% of medication reauthorizations, streamlining access for patients with chronic conditions like cystic fibrosis. This significant shift will impact over 10% of prior authorizations, though safety concerns will still necessitate reauthorizations for certain medications, including new Alzheimer's treatments.